Advancing Medicines Repurposing in the EU

OPEN DOCUMENT





Value Added Medicines Today

Value Added Medicines contribute to addressing unmet patient needs. Moving from a one-size-fits-all to a much more tailored and patient specific approach, value added medicines are one of the key components of the customisation of healthcare. By answering patients’ unmet needs, they represent a new horizon for those who are currently looking forward to a better quality of life with their treatment.

Read more

WHO WE ARE

The Value Added Medicines Group, a sector group of Medicines for Europe, aims to rethink, reinvent and optimise medicines based on known molecules by bringing untapped innovation to improve care delivery.

Read more

What's new

Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)

Read more

PHOTO GALLERY

4th Value Added Medicines Conference, Brussels
4th Value Added Medicines Conference, Brussels
30 NOVEMBER 2022
Ensuring equitable and sustainable access to medicines through a secure and resilient supply
Ensuring equitable and sustainable access to medicines...
10 NOVEMBER 2022
18th Biosimilar Medicines Conference
18th Biosimilar Medicines Conference
6-7 OCTOBER 2022

View all